Public market audit tools portfolio
Over 150 millions drug purchases records in the 29 INEFAM :LATAM market audit tools (+75 gigabytes in the central database)
Over 300 public institutions nationwide covered month by month in INEFAM:MEX®
We measure drugs, medical devices and healing material groups.
Audit Tools Specs (overall public market visibility: 90%):
Predictive model. Is a single view of a mix of all the other INEFAM:MEX® market udit tools to predict the posible issues that any given molecule can be experiencing in order to take immediate action.
We report to all of our clients personalized daily reports of published bids and tenders in order to take immediate business opportunity with over 300 mexican public institutions, reporting an average of 5,000 tenders per year.
Once the tender has been successfully assigned to a selected vendor, we present on this business intelligence report the comprehensive tool for analyzing the contracts that are to be accomplished during the year.
Once the contract has been assigned, the public institution buyer starts paying to the selected vendor. In México, by law, these contracts have to be executed minumum at a 40% range, so it’s important to keep track of those contracts that are not moving fast to the 100% or 120%.
Over 200 public institutions report in INEFAM:MEX® the product deliveries to their hospitals or warehouses.
Shows with an amazing level of detail the inventory indexes (CPM, DPN, DMN, inventory days) used by IMSS, ISSSTE, CENSIDA, INCAN & PEMEX to measure the real drug demand.
A powerful BI tool developed to analyze in detail the prescriptions made by aprox 50,000 specialty physicians in over 11 public institutions nationwide.
The only available public sector Audit to measure the medical devices and the healing materials purchased by over 100 public institutions in México.
In order to measure the business performace of the pharma company’s teams, we develop customized KPI dashboards for our clients.
Statistical data useful to know the details of the Mexican sector, like sanitary registrations, referece prices, patent durations, hopsitals sanitary certifications, public sector physicians directory, etc.
Within a single comprehensive report in a business intelligence environment, the client can perform detailed research of any given molecule in 7 different LATAM countries (México, Brazil, Colombia, Guatemala, Panamá, República Dominicana & Costa Rica), for units, values, manufacturers, sellers and institutions.
Database Export Sample for Ranitidine
Client can export data to perform market insights and comparisons for simple and clear intercountry comparisons and market shares.
INEFAM:LATAM® allows queries based on drug definition, country, institution/buyer, manufacturer, type of purchase, among other (all these based on data availability by the source).
- INEFAM:BRA® Over 1,300 MUSD per year in the market audit tool.
- INEFAM-STATS BRASIL. Prices, ex factory, PMVG, ANVISA health records issued.
Total INEFAM:COL® monitors the expenditure of drugs and medicine purchases of 535 nationwide buyers.
- INEFAM:COL® Over 2,000 MUSD per year in the market audit tool.
- INEFAM-STATS COLOMBIA. Prices, INVIMA health records issued.
- INEFAM-STATS GUA.
- INEFAM-STATS GUA.
- INEFAM-STATS CR.
- INEFAM-STATS RD.